2014
DOI: 10.1016/j.gie.2013.11.038
|View full text |Cite
|
Sign up to set email alerts
|

Perforation in colorectal stenting: a meta-analysis and a search for risk factors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
97
1
6

Year Published

2014
2014
2021
2021

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 157 publications
(107 citation statements)
references
References 118 publications
2
97
1
6
Order By: Relevance
“…22,57,59 A recent meta-analysis investigated risk factors for increased perforation rate. 25 Chemotherapy without bevacizumab was not associated with a significantly increased risk (7.0%), but use of bevacizumanb was (12.5%). Perforation rate in those who did not receive chemotherapy was 9.0%.…”
Section: Palliative Semsmentioning
confidence: 90%
See 1 more Smart Citation
“…22,57,59 A recent meta-analysis investigated risk factors for increased perforation rate. 25 Chemotherapy without bevacizumab was not associated with a significantly increased risk (7.0%), but use of bevacizumanb was (12.5%). Perforation rate in those who did not receive chemotherapy was 9.0%.…”
Section: Palliative Semsmentioning
confidence: 90%
“…[21][22][23] Systematic review and meta-analysis of retrospective data suggests an increased risk of perforation colonic perforation with stricture dilatation. 24,25 Enteral SEMS may be covered or uncovered. In the setting of malignant colonic obstruction; the two designs are equally safe and effective.…”
Section: General Considerations and Techniquementioning
confidence: 99%
“…Free perforation occurs in 3.8% to 6.9% of patients treated [27] resulting in seeding of neoplastic cells in the abdominal cavity (peritoneal carcinomatosis). Almost 70% of colon perforations occurs in the first week after stenting and it could have a negative effect on long term survival, especially in patients whose disease is potentially curable.…”
Section: Risk Of Perforation After Sems Insertionmentioning
confidence: 99%
“…Van Halsema identified as risk factors for perforation, benign etiology of the stricture, and chemotherapy with bevacizumab [27,32,33] . Type of stent: Selection of the appropriate stent is very important for outcomes, considering material, design, diameter, length, radial force, flexibility, foreshortening ratio, and delivery system but there is no evidence to indicate which stent type is superior.…”
mentioning
confidence: 99%
“…Bevacizumab is a recombinant monoclonal antibody that blocks angiogenesis, thereby inhibiting tumor growth. In patients undergoing bevacizumab treatment, perforation risks of 0.9 % in general [1] and 12.5 % following colonic stenting [2] have been reported. Recent colonoscopy (< 1 month) is a risk factor for bevacizumab-related perforation [1].…”
mentioning
confidence: 99%